Mass Torts Update - Written by Beasley Allen on Monday, August 10, 2009 15:36 - 0 Comments

Lantus linked to Cancer

The U.S. Food & Drug Administration recently notified health care professionals and patients that it is aware of four recently published observational studies that looked at the use of Lantus (insulin glargine) and possible risk for cancer in patients with diabetes. Three of the four studies suggest an increased risk for cancer associated with the use of Lantus. The studies, published in the online journal Diabetologia in June, include 301,136 patients treated with insulin in Germany, Sweden and Britain. Findings were significant enough to cause concern, and calls for further testing.

Prescription Lantus is manufactured by French drug maker Sanofi-Aventis, and is used for adults with type 2 diabetes or adults and children (six years and older) with type 1 diabetes who require long-acting insulin for the control of high blood sugar. The company also makes Lantus SoloSTAR, which is a disposable prefilled insulin pen. If you need additional information on this subject contact Ted Meadows at 800-898-2034 or Ted.Meadows@beasleyallen.com.




Leave a Reply

Comment

Comments are moderated and generally will be posted if they are on-topic and not abusive.

Powered by WP Hashcash

Recent Settlements - Sep 3, 2009 12:59 - 0 Comments

Wal-Mart parking lot case is settled

More In Recent Settlements


Featured, Toyota Litigation Update - Mar 15, 2010 8:00 - 0 Comments

Beasley Allen lawyer travels to Washington for hearings

More In Product Liability


Recalls Update - Mar 4, 2010 11:30 - 0 Comments

Innovage LLC Recalls Discovery Lamps for Children Due To Fire and Burn Hazards

More In Recalls Update